anti-CTLA-4 therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CTLA-4 therapy, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer [Phase 2]